Related Experiment Video

Updated: Jun 5, 2025

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.6K

Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches

Yi Xu1,2, Xianlu L Peng1,2, Michael P East1

  • 1Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Cancer Discovery
|December 5, 2024
PubMed
Abstract

Insights

This study maps the tumor kinome in pancreatic ductal adenocarcinoma (PDAC), identifying key targets for developing novel kinase inhibitor therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) remains a challenging malignancy with limited effective therapies.
  • Kinases play crucial roles in cancer cell signaling and represent important therapeutic targets.

Purpose of the Study:

  • To comprehensively characterize the tumor-intrinsic kinome landscape in PDAC.
  • To provide a roadmap for the strategic application of kinase inhibitors in PDAC treatment.

Main Methods:

  • Proteomic analysis of PDAC tumors to identify expressed kinases.
  • Bioinformatic analysis to map the kinome landscape and identify dysregulated kinases.

Main Results:

  • Detailed profiling of the PDAC kinome, revealing a unique set of kinases active within tumor cells.
  • Identification of specific kinase targets with potential for therapeutic intervention.

Conclusions:

  • The characterized kinome landscape offers a valuable resource for precision medicine in PDAC.
  • Targeting identified kinases holds promise for improving treatment outcomes in pancreatic cancer.

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

724
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

348

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K